Vaxcyte, Inc.
PCVX
$30.65
$1.535.25%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.75B | 2.18B | 1.45B | 1.49B | 1.08B |
| Total Receivables | 20.66M | 17.87M | 17.88M | 8.15M | 3.60M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 15.73M | 10.59M | 9.18M | 7.77M | 6.16M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.38M | 4.94M | 1.72M | 14.64M | 5.97M |
| Total Current Assets | 1.79B | 2.21B | 1.48B | 1.52B | 1.10B |
|
|
|||||
| Total Current Assets | 1.79B | 2.21B | 1.48B | 1.52B | 1.10B |
| Net Property, Plant & Equipment | 270.15M | 191.94M | 152.75M | 113.74M | 110.62M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 65.68M | 61.36M | 53.79M | 47.25M | 38.67M |
| Total Assets | 3.51B | 3.56B | 2.09B | 2.09B | 1.41B |
|
|
|||||
| Total Accounts Payable | 48.45M | 18.22M | 10.47M | 21.72M | 14.59M |
| Total Accrued Expenses | 85.84M | 95.93M | 65.09M | 58.19M | 123.64M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.89M | 9.64M | 7.29M | 7.20M | 7.11M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 140.18M | 123.79M | 82.85M | 87.10M | 145.34M |
|
|
|||||
| Total Current Liabilities | 140.18M | 123.79M | 82.85M | 87.10M | 145.34M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 65.22M | 18.32M | 18.29M | 20.22M | 22.11M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 100.00K | -- | -- | -- | -- |
| Total Liabilities | 205.50M | 142.11M | 101.14M | 107.32M | 167.45M |
|
|
|||||
| Common Stock & APIC | 4.70B | 4.67B | 3.13B | 3.00B | 2.16B |
| Retained Earnings | -1.39B | -1.25B | -1.15B | -1.02B | -924.39M |
| Treasury Stock & Other | -3.87M | 139.00K | 1.82M | 2.89M | 179.00K |
| Total Common Equity | 3.31B | 3.42B | 1.99B | 1.98B | 1.24B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.31B | 3.42B | 1.99B | 1.98B | 1.24B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.31B | 3.42B | 1.99B | 1.98B | 1.24B |
|
|
|||||